Related by context. All words. (Click for frequent words.) 71 clinical trials 71 Clinical 69 clinical trial 66 preclinical 66 oncology 64 clinical pharmacology studies 63 pharmacoeconomic 61 including eniluracil ADH 60 NP2 Enkephalin 60 clinicians 60 pharmacogenetic testing 60 CRLX# 59 clinical pharmacology 59 Numoda 59 preclinical efficacy 59 Trofex 59 clevidipine 59 phase IIa clinical 59 BrachySil TM 59 TQT studies 58 clincial 58 pharmacoeconomics 58 radiographic outcomes 58 Phase IIIB IV 58 CINQUIL 58 trastuzumab DM1 T DM1 58 pediatric 58 Factor VIIa 58 ONCONASE R 58 GLP toxicology studies 58 biostatistical 58 Phase Ib study 58 nonclinical 58 phase IIb 58 GLP toxicology 57 clinically 57 postapproval 57 BETAS 57 stage hypoxia activated 57 budesonide MMX Phase III 57 prelicensure 57 preclinical studies 57 GRN# 57 nonclinical studies 57 recurrent herpes labialis 57 constipation OIC 57 Phase IIb clinical trials 57 rALLy trial 57 translational medicine 57 PK PD 57 Prednisporin TM 57 efficacy tolerability 57 perioperative 57 Myocet 57 cannabinor 57 ALTROPANE 57 OHR/AVR# 56 Phase 2b study 56 phase IIb clinical 56 Celator 56 Phase 2b clinical 56 UltiMAb R technology 56 IND enabling 56 preclinical toxicology 56 cystinosis patients 56 Neurostep TM 56 diagnostic 56 Phase #b/#a 56 investigational therapies 56 OvaRex R 56 TKM ApoB 56 Pharma Medica 56 IMPROVE HF 56 REG1 56 IIa clinical trials 56 vivo pharmacology 56 alemtuzumab MS 56 Phase Ib 56 DXL# 56 PORxin TM platforms 56 pharmacokinetic PK study 56 MGN# 56 oncologic 56 Azedra 56 AQUAVAN R 56 gastroenterology 56 Dacogen injection 56 eTag assay 56 ColorectAlert TM 56 QOPI 56 LibiGel ® Phase III 56 IND submission 56 rheumatologic 55 bicifadine 55 therapeutic 55 ASCEND HF 55 bardoxolone 55 thorough QT 55 clinicial 55 HGS# 55 pharmacology 55 OncoVEX GM CSF 55 confirmatory Phase III 55 KRN# 55 JAK inhibitor 55 multicenter trials 55 pharmacokinetic pharmacodynamic 55 phase IIa 55 blood clot dissolver 55 ABSORB trial 55 guideline concordant 55 PDE# inhibitors 55 translational research 55 Phase IIb III 55 torezolid phosphate 55 enzastaurin 55 TRV# [001] 55 intravenous methylnaltrexone 55 gastroenterological 55 patient 55 GEM OS2 55 clinically relevant 55 QTinno TM 55 sodium thiosulfate STS 55 Cloretazine ® 55 pharmacogenetic 55 clinical informatics 55 SILENOR 55 INOmax R 55 Phase III clinical 55 teduglutide 55 Phase III clinical trials 55 cardio renal 55 Lauren Silvernail 55 MAXY VII 55 Phase Ib clinical 55 Aryplase 55 Zenvia ™ 55 biologic 55 VITAL Trial 55 ELACYT 55 BACcel 55 angiographic outcomes 55 celgosivir 55 Phase IIb clinical 55 Azedra TM 55 TMS Therapy 55 BioSante LibiGel Phase III 55 Phase IIa trial 55 renal anemia 55 placebo controlled clinical 55 Phase IIb 55 Prostate Px + 55 dexanabinol 54 Lixivaptan 54 dextofisopam 54 MYCAMINE 54 Phase 1b trial 54 metastatic sarcomas 54 Voraxaze ™ 54 biomarker discovery 54 ZFP Therapeutic 54 GCP compliant 54 Virulizin ® 54 PsychoGenics 54 Cloretazine R 54 Hedgehog agonist 54 therapeutic monoclonal antibody 54 Phase Ib IIa clinical 54 blinded randomized controlled 54 rALLy clinical trial 54 AERx iDMS 54 CYT# potent vascular disrupting 54 Prodarsan ® 54 rEEG 54 Instanyl 54 Neuradiab 54 Phase III trials 54 Phase 2a clinical trials 54 vivo preclinical 54 inhalation toxicology 54 intravenous acetaminophen 54 CoFactor 54 Phase IIa trials 54 LEUKINE 54 PEARL SC 54 Ceflatonin 54 preclinical pharmacology 54 Hyphanox 54 EXPAREL 54 Cloretazine R VNP#M 54 recombinant factor VIIa 54 Prodarsan R 54 faropenem 54 psychopharmacological 54 Phase IIa 54 Alocrest 54 invivodata 54 elotuzumab 54 Archexin 54 TBC# 54 IIa clinical 54 CRMD# 54 INTERCEPT platelets 54 Proellex TM 54 RE LY ® 54 rALLy 54 haematological cancers 54 tolevamer 54 BLA filing 54 alvimopan 54 talactoferrin 54 SNT MC# 54 PSN# [002] 54 Referenced EEG ® 54 Hemopurifier 54 postoperative ileus POI 54 Urocortin 2 54 Exherin TM 54 PREOS 54 interventional therapies 54 Altastaph 54 phase IIb study 54 Edwards SAPIEN valve 54 anti angiogenic agents 54 candidate CRLX# 54 immatics 54 oral talactoferrin 54 reslizumab 54 pharmacokinetic 54 AeroLEF TM 54 Hedgehog antagonist 54 ProSavin 54 XmAb 54 International Nasdaq PRAI 54 BEMA TM Fentanyl 54 REVEAL Registry 54 bardoxolone methyl 54 Rasagiline 54 NTx ® -# 54 NTDDS platform 54 OvaRex 54 pharmacodynamic PD 54 pharmacological therapies 54 pivotal bioequivalence 54 PDE4 inhibitor 54 liprotamase 54 PREOS R 54 Combo Stent 54 clinician 54 Ketotransdel TM 54 postmarket safety 54 HORIZONS AMI trial 54 RE LY 54 INCB# [001] 53 phase Ib 53 cardiometabolic 53 Ketotransdel 53 diabetic neuropathic pain 53 tonabersat 53 Zenvia Phase III 53 MabThera rituximab 53 prehospital 53 CA9 SCAN 53 postmarketing surveillance 53 SUTENT ® 53 Phase #b/#a trial 53 Phase #/#a 53 EDEMA3 trial 53 midstage clinical 53 tezampanel NGX# 53 velafermin 53 oral PTH 53 CAPHOSOL 53 ALN PCS 53 JAK2 inhibitors 53 Clinical Research 53 ALN HTT 53 Zemplar Capsules 53 Capesaris 53 Aerosurf 53 pharmacogenetics 53 BRIM3 53 isavuconazole 53 Glenveigh 53 viral kinetics 53 Dalbavancin 53 ganaxolone 53 biologics 53 patients 53 BNC# 53 MOZOBIL 53 gefitinib Iressa 53 pharmacodynamic 53 DPX Survivac 53 Proxinium TM 53 Phase 2a clinical 53 ProTrials Research 53 pharmacovigilance 53 GI motility disorders 53 randomized Phase IIb 53 GAMMAGARD 53 ancrod 53 EOquin 53 INxin TM 53 ePRO 53 acute decompensated heart 53 OLYMPIA registry 53 Valdoxan 53 postoperative ileus 53 NSABP 53 ADAGIO study 53 Phase 2a trial 53 POSIDUR TM 53 MAXY alpha 53 mecarbil 53 tasimelteon 53 rxRNA 53 Neo Kidney Augment ™ 53 KL4 surfactant 53 p# inhibitor 53 atherosclerosis regression 53 immunological diseases 53 ruxolitinib 53 Ereska 53 EOquin TM 53 efficacy 53 cardiothoracic surgical 53 registrational 53 ACTILON 53 Removab 53 prospective multicenter study 53 oxypurinol 53 Phase 1a clinical 53 Stimuvax R 53 ganetespib 53 eculizumab therapy 53 EGEN 53 INS# [001] 53 HuMax EGFr 53 RGB # 53 NovaBay Aganocide compounds 53 metaanalysis 53 TLK# 53 Phase 2b trial 53 PHX# 53 biomarker 53 KineMed 53 OncoVEX 53 Alequel 53 SUCCEED trial 53 CB1 antagonists 53 Zevalin consolidation 53 ViaCyte 53 pertuzumab 53 galiximab 53 peri operative 53 adipiplon 53 Aplidin 53 pharmacogenomics 53 CHAMPION PCI 53 MYDICAR 53 Pyridorin 53 neratinib 53 solid organ transplantation 53 IMA# 53 Sulonex TM 53 ospemifene 53 AZX# 53 lomitapide 53 data management Clintrial 53 fosbretabulin 53 perfusion CT 53 AZILECT ® 53 opioid induced constipation 53 ALGRX 53 YONDELIS 53 luliconazole 53 obatoclax 53 interventional cardiac 53 PRT# 53 Phase IIa clinical 53 genomic biomarker 53 pharmacotherapeutic 53 Phase Ia 53 QTinno 53 EGS# 53 Cloretazine 53 Vicinium TM 53 rFactor XIII 53 davunetide intranasal AL 53 hematological malignancy 53 Adlea 53 oral ridaforolimus 53 Acute Decompensated Heart Failure 53 immunotherapeutic vaccine 53 Veronate 53 R#/MEM # 53 Surfaxin LS 53 preclinically 53 Glybera R 53 refractory angina 53 deforolimus 53 oxymorphone ER 53 Phase Ib II 53 Zybrestat 53 multicenter clinical trials 53 relapsed multiple myeloma 53 ACORN CRO 53 oncology cardiology 53 Dataflow Manager 53 Itopride 53 methylnaltrexone 53 RSD# oral 53 Clinical Trial 53 Electronic Brachytherapy 53 biomarker identification 53 LibiGel Phase III 53 noninfectious uveitis 53 forodesine 53 aesthetic dermatological conditions 53 vemurafenib 53 Rheos System 52 Icatibant 52 ChronVac C R 52 personalized cellular immunotherapy 52 pharmacokinetic PK 52 palifosfamide 52 eniluracil 52 prospective nonrandomized 52 ORENCIA R 52 acute ischemic stroke 52 Viprinex 52 randomized clinical trials 52 interventional neuroradiology 52 Actilon 52 CardioFit 52 cangrelor 52 Renal Cell Carcinoma RCC 52 HQK 52 zileuton CR 52 lintuzumab 52 HORIZONS AMI 52 Sulonex 52 Phase IIIb study 52 cytopathology 52 Triapine R 52 neurosurgical 52 rhC1INH 52 kidney urologic 52 Syndax Pharmaceuticals Inc. 52 TKM PLK1 52 DAPT 52 RE COVER 52 Cortex AMPAKINE 52 Neovasc Reducer 52 PORxin TM 52 nicotinic alpha 7 52 aerosolized KL4 surfactant 52 Zemiva TM 52 Fibrin Pad 52 diagnostic prognostic 52 Lymphoseek ® 52 vidofludimus 52 Huntexil 52 leading oral taxane 52 vernakalant hydrochloride 52 Clinical Trials 52 EP #R 52 EECP R 52 orally inhaled migraine 52 GGF2 52 Stedivaze 52 Androxal TM 52 ataluren 52 invasive candidiasis 52 eRT 52 Genasense ® 52 fidaxomicin Phase 3 52 www.nextrials.com 52 pivotal Phase III 52 Inc. Nasdaq NLTX 52 pharmacogenetic tests 52 dacetuzumab 52 Aurora kinase inhibitors 52 antithrombotic therapy 52 Medifacts 52 revision hip arthroplasty 52 MERLIN TIMI 52 sulodexide 52 Corlux 52 Tarek Sherif CEO 52 kinase profiling 52 alvespimycin 52 pain palliation 52 clinicaltrials 52 canakinumab 52 epigenetic therapies 52 IIa trials 52 human microdosing 52 phase III ACCLAIM 52 Hedgehog inhibitor 52 Phase IIb trial 52 Cx# [002] 52 Cleviprex TM clevidipine 52 DFCI 52 Adlea TM 52 pediatric rheumatology 52 Aurexis 52 NeuroFlo 52 eTag assays 52 Aethlon Hemopurifier R 52 procedural sedation 52 EECP ® 52 Nonclinical 52 OZURDEX ® 52 JAK2 inhibitor 52 Altrazeal TM Silver 52 hematology microbiology 52 rindopepimut 52 pharmacologic treatments 52 Meta analyzes 52 therapeutics 52 convenient dosing regimen 52 Phase IIIb clinical 52 oral prodrug 52 pharmacodynamic properties 52 Kendle Nasdaq KNDL 52 micafungin 52 Allovectin 7 52 sacral nerve stimulation 52 companion diagnostics 52 entinostat 52 confirmatory clinical 52 GEM OS1 52 EECP ® therapy 52 Fabry Disease 52 Durata 52 midstage trials 52 CLORETAZINE TM VNP#M 52 AMPAKINE CX# 52 IMC #B 52 zanolimumab 52 CytoFab ™ 52 FavId 52 Nanobody 52 subcutaneous immunoglobulin 52 evaluating Nexavar 52 FOLOTYN ® 52 MEND CABG 52 CARE HF 52 Toraymyxin TM 52 Phase IIIb 52 opioid analgesia 52 Mipomersen 52 Plenaxis TM 52 ophthalmology 52 riociguat 52 PRIMO CABG 52 SinuNase TM 52 dermaPACE TM 52 ophthalmology dermatology cardiovascular disease 52 omacetaxine 52 phase IIIb 52 R#/MEM 52 ReN# 52 COU AA 52 IIa trial 52 cGMP manufacture 52 ALN TTR# 52 DermTech International 52 adipose derived stem cell 52 Phase III randomized controlled 52 abstracts summarizing 52 EndoTAG TM 52 phase IIb III 52 dirucotide MBP# 52 Referenced EEG 52 Phase 1b clinical 52 therapeutic antibody 52 tafamidis 52 NTDDS 52 NEUMUNE 52 recombinant PSMA vaccine 52 visilizumab 52 Celacade TM 52 bioabsorbable stent 52 Zoraxel 52 tecarfarin 52 Ophena 52 ASONEP 52 GeneSightRx 52 Squalamine 52 M6G 52 bioanalytical laboratories 52 Cethrin 52 bioequivalency 52 therapeutic regimens 52 cancer immunotherapies 52 cartilage regeneration 52 bioanalysis 52 Tolerx 52 UltiMAb ® 52 dirucotide 52 Cutanea 52 lenalidomide Revlimid R 52 everolimus eluting stents 52 Desmoteplase 52 Vilazodone 52 molecular pathology 52 Hepatocellular Carcinoma HCC 52 cerebral oximetry 52 ESBA# 52 Intarcia 52 urology oncology 52 daptomycin 52 tolerability profiles 52 prospective longitudinal 52 recurrent glioma 52 HEOR 52 OvaRex ® MAb 52 PREGNANT Study 52 Sequenom CMM 52 EmbraceAC 52 GSK# [002] 52 Q#IR 52 TriGrid 52 PMA submission 52 oncology virology 52 topically applied SEPA 52 Onalta 52 PRECISE trial 52 ticagrelor Brilinta 52 Facet Solutions 52 ACRIN 52 EDEMA3 52 almorexant 52 TACI Ig 52 predictive toxicology 52 pharmaco 52 opioid induced bowel dysfunction 52 teriflunomide 52 Bicifadine 52 Prednisporin 52 TNFerade TM 52 DDP# 52 fibrin sealant 52 OMAPRO 52 BioLife enabling 52 TELINTRA 51 Elocalcitol 51 Preclinical 51 Simulect 51 AzaSite Plus 51 Oral NKTR 51 RhuDex 51 ENDEAVOR IV 51 punctal plug drug 51 Val HeFT 51 Accelovance 51 Neo Kidney Augment 51 microplasmin Phase III 51 Chrysalin 51 oral methylnaltrexone 51 trastuzumab DM1 51 ENMD # 51 ostarine 51 Tectin TM 51 lexidronam injection 51 phase IIb trial 51 HspE7 51 Dynogen 51 CIP ISOTRETINOIN 51 Puricase PEG uricase 51 Intraject 51 severe hypercholesterolemia 51 Avastin adjuvant 51 radezolid 51 microRNA profiling 51 Ophena TM 51 pharmacotherapies 51 Aganocide 51 thetreatment 51 Gag polymorphisms 51 Plicera 51 TOCOSOL Paclitaxel 51 coronary intervention 51 MyVax ® 51 Solazed 51 novel oral anticoagulant 51 Phase III TRIST 51 Amigal 51 clinically meaningful 51 Zavesca r 51 SEPET TM 51 XmAb ® 51 PROSTVAC TM 51 Clonicel 51 Rezular 51 investigational 51 VEGF Trap 51 AVN# [001] 51 PICSO ® 51 GLPG# 51 GED aPC 51 Panzem R NCD 51 GI endoscopy 51 randomized trials 51 intranasal insulin 51 oncology dermatology 51 Quinamed 51 neurology cardiology 51 HIV integrase inhibitors 51 RELOVAIR ™ 51 mechanical thrombectomy 51 FFR measurement 51 tiapamil 51 analgesic efficacy 51 FVIIa 51 BioMAP 51 unblinding 51 Mepact 51 Rhucin R 51 RIGScan CR 51 senicapoc 51 haematologic 51 Firazyr ® 51 catheter occlusion 51 OPTTX 51 therapeutic armamentarium 51 Novolimus 51 Phase 1b 51 HeFH 51 Sudhir Agrawal D.Phil 51 CR# vcMMAE 51 Xcytrin R 51 Kendle NASDAQ KNDL 51 treating neuropathic pain 51 SYNTAX trial 51 Cethromycin 51 Neuradiab TM 51 XL# SAR# 51 Bioaccelerate compounds under 51 HERmark assay 51 AA Amyloidosis 51 INFUSE ® 51 MAGE A3 ASCI 51 sunitinib malate 51 HGS ETR1 51 psychometrically sound 51 EchoCRT 51 non alcoholic steatohepatitis 51 PANVAC VF 51 selective androgen receptor modulator 51 oral taxane 51 elacytarabine 51 CellerateRx 51 farletuzumab 51 interventional pulmonology 51 fostamatinib 51 Vascular Wrap 51 Ceflatonin R 51 Vascular Wrap TM 51 pharmacoepidemiology 51 AFRS TM 51 CB2 selective receptor agonist 51 cardiotoxic effects 51 molecular profiling 51 Evoltra ® 51 huN# DM1 51 Memryte 51 HealthCore 51 Phase 2b clinical trials 51 Nanobody ® 51 indicates cardio circulatory 51 renin inhibition 51 BEXXAR 51 HCV polymerase inhibitor 51 Sernova Cell Pouch 51 elagolix 51 oral RSD# 51 BioDisc 51 KuDOS 51 FFR measurements 51 MGd 51 Mpex 51 predictive biomarkers 51 injectable formulations 51 RhuDex ® 51 Annamycin 51 REMINYL ® 51 XP #L 51 favorable pharmacokinetic profile 51 inVentiv Clinical 51 tezampanel 51 Cancidas 51 Soliris TM eculizumab 51 punctal plug delivery 51 Cardio Vascu Grow 51 omecamtiv mecarbil 51 resuscitative measures 51 anticoagulation 51 BRAF inhibitor 51 IV acetaminophen 51 Medidata Rave 51 Sigma Tau SpA 51 balsalazide tablet 51 molecular imaging radiopharmaceutical 51 novel therapeutic antibodies 51 IRX 2 51 CIPN 51 AVADO 51 Dr Gillian Braunold 51 prostone 51 LymphoStat B 51 Xanodyne 51 viral kinetic 51 OXi# 51 candidate TNFerade biologic 51 Serdaxin 51 COR Analyzer 51 rBChE 51 tumor immunology 51 retrospective observational study 51 Cellegesic 51 Altrazeal ® 51 AQ4N 51 RelayHealth securely processes 51 BST CarGel R 51 PEG PAL 51 Med eMonitor System 51 placebo controlled Phase III 51 pharmacogenomic testing 51 oncology neurology 51 psychiatry neurology 51 pharmacologic 51 Zavesca R 51 pediatric bipolar disorder 51 Phase IIB 51 molecular oncology 51 rt PA 51 Pervasis 51 gynecologic procedures 51 YONDELIS R 51 Fentanyl TAIFUN R 51 Targeted Chemotherapy 51 randomized blinded 51 QLT# 51 renal 51 perinatal 51 CBLC# 51 external counterpulsation systems 51 Metricath Gemini 51 pediatric intensivists 51 IL# PE#QQR 51 immunology 51 biliary tract cancer 51 CytoFabTM 51 CaPre TM 51 Phase IIb trials 51 crofelemer 51 clinically validated 51 Fx #A 51 CDRD 51 Nasulin 51 biased ligand 51 tubulin inhibitor 51 multicenter Phase II 51 investigational HCV polymerase 51 temsirolimus Torisel ® 51 neuroimmunology 51 StemEx R 51 ADME 51 PLK1 SNALP 51 Tragara Pharmaceuticals Inc. 51 physicians 51 Nivestim 51 CINTREDEKIN BESUDOTOX 51 SPARLON 51 ularitide 51 BR.# 51 PK PD modeling 51 OvaRex MAb 51 clincal 51 endocrinology oncology 51 vinca alkaloid 51 personalized immunotherapy 51 rHuPH# 51 Sunrise Ambulatory Care 51 Exelixis compounds 51 radiolabeled TM# 51 Oasmia 51 lumiliximab 51 Phase III VISTA 51 REALITY Trial 51 B. Lynne Parshall 51 subcutaneous formulation 51 AcelRx 51 budesonide foam 51 PFO migraine 51 bosutinib 51 systemic RNAi 51 UPLYSO 51 dermatologic 51 postmarket surveillance 51 eprotirome 51 Proxinium 51 Tovaxin ® 51 double blinded randomized 51 Opexa 51 vosaroxin 51 CCR9 antagonist 51 CCX# 51 tolerability 51 PD2i Analyzer 51 Personalized Oncology 51 Entereg R 51 LibiGel ® 51 HCD# [002] 51 anidulafungin 51 MEND CABG II 51 null responder 51 clazosentan 51 interprofessional education 51 Catabasis 51 vilazodone 51 pharmacokinetic studies 51 CLARITY study 51 safinamide 51 Jean Pierre Sommadossi Ph.D. 51 ToleroMune 51 torcetrapib atorvastatin 51 EC Cysteamine 51 CURE AF 51 COMFORT II 51 transplantation immunology 51 TRIST study 51 prospective multicenter 51 Fibrocaps 51 PD2i ® 51 Cogane 51 TRO# 51 ATIR TM 51 MyVax personalized immunotherapy 51 OnDose TM 51 AERx 51 AssureRx 51 REMOXY ® 51 Aethlon Hemopurifier ® 51 briakinumab 50 ZEVALIN ® 50 isoform selective 50 incyclinide 50 maribavir 50 Zingo TM 50 NATRECOR ® 50 Wellstat 50 schizophrenia CIAS 50 Nanobodies ® 50 plaque excision 50 antiangiogenic agents 50 herpetic keratitis 50 ICA # 50 VTE prevention 50 tipranavir 50 Vasogen Celacade TM 50 Panzem R 50 Vion Pharmaceuticals 50 Posidur 50 metabolite identification 50 targeted radiotherapeutic 50 non nucleoside 50 lorvotuzumab mertansine 50 hematologic oncology 50 intranasal formulation 50 aripiprazole Abilify 50 Liprotamase 50 preclinical pharmacokinetic 50 OFIRMEV 50 SJTRI 50 NEXTERONE 50 candidates Dyloject TM 50 tremelimumab 50 Perforomist ™ Inhalation Solution 50 oral antiviral 50 AspenBio 50 optimal dosing regimens 50 ADVANCE PD 50 daclizumab 50 TYZEKA 50 eosinophilic asthma 50 OraTest R 50 RESOLUTE clinical 50 gepirone ER 50 THALOMID 50 Manja Bouman CEO 50 Acute Coronary Syndromes ACS 50 Periowave TM Photodisinfection System 50 NEUGENE antisense